IGF1 and chronic kidney disease: In a subsequent RCT of the same group, a lower IGF-1 dosage (50 μg/kg twice daily) and intermittent treatment protocol, with cycles of 4-day treatment interrupted by 3 days off treatment, in patients with stage 5 CKD (GFR 6–15 ml/min/1.73 m2) was used [178].